Sponsor or institution

Clinical trials and research at Epiliquid Holding, Inc

• 3Clinical trials
• 1Country

Newest trials

All recruiting trials (3)

• Blood test that looks for DNA methylation to detect colorectal cancer using Delta-HLD

  This will test a blood-based DNA methylation assay called Delta-HLD to see if it can detect colorectal cancer in people aged 45–75 undergoing routine screening colonoscopy.

  Recruiting Epiliquid Holding, Inc · Mendoza, Mendoza Province · NCT07168876

• Detecting hepatocellular carcinoma with the Delta-HLD blood test

  This project will test whether the Delta-HLD liquid biopsy can detect hepatocellular carcinoma (HCC) using blood and matched liver tissue from people with HCC and from people with cirrhosis without cancer.

  Recruiting Epiliquid Holding, Inc · Mendoza · NCT07148310

• Blood-based delta-HLD methylation test for detecting colorectal cancer

  This will try a blood-based delta-HLD methylation test to see if it can detect colorectal cancer in people scheduled for colonoscopy or colorectal surgery.

  Recruiting Epiliquid Holding, Inc · Mendoza · NCT07148297

Quick answers

How many clinical trials run by Epiliquid Holding, Inc are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Argentina. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →